Purchase Order HHSN272201700815P
Award Date 7/5/17
Potential Completion Date 7/5/18
Potential Value $101K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Burien, WA 98168, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a $24,350.00 firm-fixed-price purchase order contract to Stemcell Technologies Inc., a foreign-owned, for-profit organization, for the provision of human cell enrichment kits. The contract has a completion date of May 31, 2019 and was awarded on May 15, 2018. This contract is not set aside for any specific business type. Stemcell Technologies Inc. is a...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a $24,605 firm fixed-price purchase order to Stemcell Technologies Inc., a foreign-owned for-profit organization, for the delivery of Human Cell Enrichment Kits. This contract did not have a set-aside designation. Stemcell Technologies Inc. is a subsidiary of the Canadian company Stemcell Technologies, which develops specialized biological materials,...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Stemcell Technologies Inc., a Canadian biotechnology company. The contract is for the delivery of EasySep Enrichment Kits, which are specialized cell separation products used in biomedical research, particularly for studies in areas like stem cell research, immunology, cancer, and infectious diseases. The...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $12,670.00 firm fixed price purchase order to Stemcell Technologies Inc., a Canadian-owned for-profit company, for CD4 EASYSEP NEGATIVE SELECTION KITS. This award was not set aside for any particular business type. Stemcell Technologies Inc. is an experienced federal contractor that frequently provides specialized biological materials, lab supplies, scientific...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a subagency of the Department of Health and Human Services (HHS), to Stemcell Technologies Inc. on June 13, 2016. The contract, with a ceiling value of $24,134.75, is for the delivery of EasySep kits, which are specialized cell separation and isolation products used in biomedical research. Stemcell Technologies Inc. is a Canadian biotechnology company that serves as...
- Stemcell Technologies Inc. received a $18,916.80 firm fixed-price purchase order from the National Institute of Allergy and Infectious Diseases (NIAID) on September 1, 2021, for EasySep Human Kits with an ultimate completion date of July 1, 2022. The contract was issued without a small business set-aside designation. The procurement was structured as an administrative de-obligation of unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a), with closure...
- The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a $17,450.00 Firm Fixed Price purchase order contract to Stemcell Technologies Inc., a Canadian-owned for-profit organization, for the delivery of HUMAN CD8 KITS. The contract has a completion date of June 22, 2018 and does not have a set-aside designation. Stemcell Technologies Inc. is an active supplier of specialized biological materials, laboratory...
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services (HHS), awarded a $45,760.35 firm-fixed-price purchase order contract to Stemcell Technologies Inc. on January 31, 2017. The contract is for an "Immunomagnetic Cell Separator" and had a completion date of February 28, 2017. Stemcell Technologies Inc. is a Canadian biotechnology company that specializes in cell culture media, cell separation systems, and...
- The U.S. National Institute of Allergy and Infectious Diseases, a civilian agency within the Department of Health and Human Services, awarded a Firm Fixed Price Blanket Purchase Agreement (BPA) Call contract worth $14,934.75 to Stemcell Technologies Inc., a foreign-owned for-profit biotechnology company. The contract is for the supply of the EASYSEP NEGATIVE HUMAN CD4 KIT, Catalog #19052. This product supports biomedical and scientific research, particularly in areas like infectious diseases,...
- This is a $24,970.00 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Stemcell Technologies Inc., a Canadian biotechnology company. The contract, which has no set-aside designation, is for the delivery of various cell culture research products, such as cell isolation kits, cell culture media, and automated cell separation instruments, to support biomedical...